Twist Bioscience Corporation (BIT:1TWST)
Italy
· Delayed Price · Currency is EUR 29.09
+1.43 (5.17%)
At close: May 12, 2025
Twist Bioscience Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2016 - 2019 |
| Revenue | 347.68 | 312.97 | 245.11 | 203.57 | 132.33 | 90.1 | Upgrade
|
| Revenue Growth (YoY) | 25.30% | 27.69% | 20.41% | 53.83% | 46.87% | 65.67% | Upgrade
|
| Cost of Revenue | 185.31 | 179.63 | 155.38 | 119.33 | 80.62 | 61.41 | Upgrade
|
| Gross Profit | 162.37 | 133.35 | 89.73 | 84.24 | 51.71 | 28.69 | Upgrade
|
| Selling, General & Admin | 229.79 | 218.4 | 189.74 | 212.95 | 135.9 | 103.27 | Upgrade
|
| Research & Development | 88.83 | 90.85 | 106.89 | 120.31 | 69.07 | 43.01 | Upgrade
|
| Operating Expenses | 318.61 | 309.25 | 296.63 | 333.26 | 204.97 | 146.27 | Upgrade
|
| Operating Income | -156.24 | -175.9 | -206.9 | -249.02 | -153.26 | -117.58 | Upgrade
|
| Interest Expense | -0.2 | -0.03 | -0.01 | -0.08 | -0.37 | -0.79 | Upgrade
|
| Interest & Investment Income | 13.32 | 15.34 | 14.37 | 3.06 | 0.44 | 1.5 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.74 | -2.65 | -0.67 | -1.09 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -145.85 | -163.24 | -193.21 | -247.13 | -153.19 | -116.87 | Upgrade
|
| Merger & Restructuring Charges | - | - | -9.38 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 4.61 | - | - | Upgrade
|
| Asset Writedown | -44.93 | -44.93 | -6.79 | - | - | - | Upgrade
|
| Legal Settlements | - | - | - | - | - | -22.5 | Upgrade
|
| Other Unusual Items | - | - | 5.91 | 14.25 | -0.84 | -0.18 | Upgrade
|
| Pretax Income | -190.78 | -208.17 | -203.47 | -228.27 | -154.03 | -139.55 | Upgrade
|
| Income Tax Expense | 0.37 | 0.56 | 1.15 | -10.41 | -1.93 | 0.38 | Upgrade
|
| Net Income | -191.15 | -208.73 | -204.62 | -217.86 | -152.1 | -139.93 | Upgrade
|
| Net Income to Common | -191.15 | -208.73 | -204.62 | -217.86 | -152.1 | -139.93 | Upgrade
|
| Shares Outstanding (Basic) | 59 | 58 | 57 | 54 | 48 | 39 | Upgrade
|
| Shares Outstanding (Diluted) | 59 | 58 | 57 | 54 | 48 | 39 | Upgrade
|
| Shares Change (YoY) | 2.61% | 1.99% | 5.57% | 11.68% | 23.12% | 42.71% | Upgrade
|
| EPS (Basic) | -3.25 | -3.60 | -3.60 | -4.04 | -3.15 | -3.57 | Upgrade
|
| EPS (Diluted) | -3.25 | -3.60 | -3.60 | -4.04 | -3.15 | -3.57 | Upgrade
|
| Free Cash Flow | -65.49 | -69.17 | -170.25 | -226.24 | -139.31 | -152.12 | Upgrade
|
| Free Cash Flow Per Share | -1.11 | -1.19 | -2.99 | -4.20 | -2.89 | -3.88 | Upgrade
|
| Gross Margin | 46.70% | 42.61% | 36.61% | 41.38% | 39.08% | 31.85% | Upgrade
|
| Operating Margin | -44.94% | -56.20% | -84.41% | -122.33% | -115.81% | -130.50% | Upgrade
|
| Profit Margin | -54.98% | -66.69% | -83.48% | -107.02% | -114.94% | -155.31% | Upgrade
|
| Free Cash Flow Margin | -18.84% | -22.10% | -69.46% | -111.14% | -105.27% | -168.84% | Upgrade
|
| EBITDA | -131.1 | -147.07 | -178.49 | -232.51 | -143.51 | -110.9 | Upgrade
|
| EBITDA Margin | -37.71% | -46.99% | -72.82% | -114.22% | -108.45% | -123.09% | Upgrade
|
| D&A For EBITDA | 25.14 | 28.83 | 28.41 | 16.51 | 9.75 | 6.68 | Upgrade
|
| EBIT | -156.24 | -175.9 | -206.9 | -249.02 | -153.26 | -117.58 | Upgrade
|
| EBIT Margin | -44.94% | -56.20% | -84.41% | -122.33% | -115.81% | -130.50% | Upgrade
|
| Advertising Expenses | - | 5.2 | 2.9 | 2.4 | 2.5 | 1.2 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.